Cholestyramine: use as a new therapeutic approach for chlordecone (kepone) poisoning.
about
Possible estuary-associated syndrome: symptoms, vision, and treatmentMethods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations.Residential and recreational acquisition of possible estuary-associated syndrome: a new approach to successful diagnosis and treatmentA review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxinsIntestinal disease and the urban environmentEffect of colestimide on the concentrations of polychlorinated dibenzo-p-dioxins, polychlorinated dizenzofurans, and polychlorinated biphenyls in blood of Yusho patientsTherapeutic approaches for chlordecone poisoning in humans.The role of plasma proteins in the transport and distribution of chlordecone (Kepone) and other polyhalogenated hydrocarbons.Estrogenic activity of the insecticide chlordecone in the reproductive tract of birds and mammals.Chlordecone-induced hepatic dysfunction.Enhancement of xenobiotic elimination: role of intestinal excretion.Metabolic disposition of antihyperlipidemic agents in man and laboratory animals.ATSDR evaluation of health effects of chemicals. II. Mirex and chlordecone: health effects, toxicokinetics, human exposure, and environmental fate.Procedures to enhance withdrawal of xenobiotics from chickens.Effect of mineral oil and/or cholestyramine in the diet on biliary and intestinal elimination of 2,4,5,2',4',5'-hexabromobiphenyl in the rhesus monkey.Enhanced withdrawal from chickens of hexachlorobenzene (HCB) and pentachlorophenol (PCP) by colestipol, mineral oil, and/or restricted feeding.The excretion of pesticides in saliva and its value in assessing exposure.Enteric transport of chlordecone (Kepone) in the rat.Continuous ingestion of different chlordecone (Kepone) concentrations and changes in quail reproduction.Neurochemical correlates of chlordecone neurotoxicity.Chlordecone poisoning: a case study in approaches for detoxification of humans exposed to environmental chemicals.Spermotoxicity and tissue accumulation of chlordecone (Kepone) in male rats.High-density lipoproteins decrease the biliary concentration of chlordecone in isolated perfused pig liver.Effect of cholestyramine on the disposition of pentachlorophenol in rhesus monkeys.Detoxification of chlordecone poisoned rats with chlorella and chlorella derived sporopollenin.
P2860
Q24536805-0B194128-CD98-427E-BCC4-78EC3B762E7DQ24814147-E651063D-8D82-499D-939C-6528675E0606Q24814777-B678C5F7-4E65-431A-96B3-51525D7D6AB5Q28382991-AE25F5C4-F3F9-484B-8F84-8D839BDDDA01Q35135304-39684904-34E3-4B50-A796-E0EC910CF448Q36969287-91ACAE62-B8A4-4F1E-BF55-1D3D146D9B3CQ38584385-8BD90473-E019-4967-982E-0FC7F59C76BDQ39552866-98BAFE8C-FA11-4462-A8FA-A9B77D7BBFD5Q40102977-72676303-80E3-4723-A1DA-7FA3058C76D4Q40102983-2B88C4FB-504C-4F4C-AC37-E7B94DBA4522Q40200353-2D4E5880-742A-4C8E-A3F6-D47F0A8A108CQ40303400-406DE001-D411-4E4A-9875-3EF2E966FC26Q41046093-FDEAC902-723C-4B06-B0F8-9C84B7AB44D1Q42205417-7A35000E-969A-4003-83FD-593A26B4C315Q42245722-73BA1D62-2E88-4479-A3FD-1AC13A30295AQ43988389-3B37CE0A-680E-46E8-97ED-6E066D3BE77FQ52516074-C68143BA-DA93-4FFE-96A0-3AB9D809F1BAQ52516437-0761095A-26BD-46CB-8ABF-567755598F41Q52516645-79AB2D6B-A0C8-483F-B517-1D311B044A13Q52516649-FCE8FBC4-CE26-425E-B2C6-05AF56948F4CQ52516839-0A32010F-DD46-4CA6-85F3-E4DD2EFDA000Q52517329-55313A0A-FD1B-455A-B09D-FAFDC3EF9F90Q52517624-7D607CE5-5066-4508-B533-64FAD8ADA55FQ52531357-D1DF5CAF-FFF3-4E66-9BC4-049F90364C1FQ54485350-A0D8223E-B46F-428B-87B3-F6E5331D226E
P2860
Cholestyramine: use as a new therapeutic approach for chlordecone (kepone) poisoning.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Cholestyramine: use as a new therapeutic approach for chlordecone (kepone) poisoning.
@en
Cholestyramine: use as a new therapeutic approach for chlordecone
@nl
type
label
Cholestyramine: use as a new therapeutic approach for chlordecone (kepone) poisoning.
@en
Cholestyramine: use as a new therapeutic approach for chlordecone
@nl
prefLabel
Cholestyramine: use as a new therapeutic approach for chlordecone (kepone) poisoning.
@en
Cholestyramine: use as a new therapeutic approach for chlordecone
@nl
P2093
P356
P1433
P1476
Cholestyramine: use as a new therapeutic approach for chlordecone (kepone) poisoning.
@en
P2093
P304
P356
10.1126/SCIENCE.74852
P407
P577
1978-02-01T00:00:00Z